Anju Singh, DVM, Ph.D.

Dr. Anju Singh obtained her Bachelor of Veterinary Sciences degree (DVM) from G. B. Pant University, India. She came to the USA in 2003 and obtained her Ph.D. from the University of Wisconsin-Madison where she studied mechanisms of T cell memory to viral infections. Dr. Singh transitioned to Harvard University for her postdoctoral fellowship where she investigated cross talk between the immune and skeletal systems, anabolic regulators of bone development and the biology of skeletal progenitor cells. Dr. Singh joined National Center for Advancing Translational Sciences (NCATS), NIH as a Translational Research Scientist in 2012 where she gained extensive experience developing complex cellular models for drug discovery and implementing high throughput screens for autoimmune disorders and cancer. Dr. Singh joined the Immunology Review Branch, NIAID as a Scientific Review Officer in 2019 and transitioned to the Immuno-Oncology Branch at the NCI in 2020. Her programmatic research interests include pediatric immunotherapy, cellular immunotherapies, immunometabolism, modulation of tumor microenvironment, antitumor immunity and development of new technologies and targets.